Tachycardia-induced cardiomyopathy in de novo heart failure: prevalence, short-term outcomes, and the role of guideline-directed therapy in ejection fraction improvement

Alberto Esteban-Fernández, Inés Gómez-Otero, Silvia López-Fernández, Raquel López-Vilella, Francisco Pastor-Pérez, Óscar Otero-García, Miguel Rodríguez-Santamarta, David García-Vega, Paula Fluvià, Víctor Donoso-Trenado, Ester Sánchez-Corral, José Manuel García-Pinilla, Juan Luis Bonilla-Palomas, Andrea López López, José Ramón González-Juanatey, Luis Almenar Bonet

Open source

DOI
10.1007/s00392-025-02663-y
Published
2025-05-06
Container
Clinical Research in Cardiology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00392-025-02663-y,
  title = {Tachycardia-induced cardiomyopathy in de novo heart failure: prevalence, short-term outcomes, and the role of guideline-directed therapy in ejection fraction improvement},
  author = {Alberto Esteban-Fernández and Inés Gómez-Otero and Silvia López-Fernández and Raquel López-Vilella and Francisco Pastor-Pérez and Óscar Otero-García and Miguel Rodríguez-Santamarta and David García-Vega and Paula Fluvià and Víctor Donoso-Trenado and Ester Sánchez-Corral and José Manuel García-Pinilla and Juan Luis Bonilla-Palomas and Andrea López López and José Ramón González-Juanatey and Luis Almenar Bonet},
  year = {2025},
  journal = {Clinical Research in Cardiology},
  doi = {10.1007/s00392-025-02663-y},
  url = {https://doi.org/10.1007/s00392-025-02663-y}
}

RIS

TY  - JOUR
TI  - Tachycardia-induced cardiomyopathy in de novo heart failure: prevalence, short-term outcomes, and the role of guideline-directed therapy in ejection fraction improvement
AU  - Alberto Esteban-Fernández
AU  - Inés Gómez-Otero
AU  - Silvia López-Fernández
AU  - Raquel López-Vilella
AU  - Francisco Pastor-Pérez
AU  - Óscar Otero-García
AU  - Miguel Rodríguez-Santamarta
AU  - David García-Vega
AU  - Paula Fluvià
AU  - Víctor Donoso-Trenado
AU  - Ester Sánchez-Corral
AU  - José Manuel García-Pinilla
AU  - Juan Luis Bonilla-Palomas
AU  - Andrea López López
AU  - José Ramón González-Juanatey
AU  - Luis Almenar Bonet
PY  - 2025
JO  - Clinical Research in Cardiology
DO  - 10.1007/s00392-025-02663-y
UR  - https://doi.org/10.1007/s00392-025-02663-y
ER  - 

APA

Esteban-Fernández, A., Gómez-Otero, I., López-Fernández, S., López-Vilella, R., Pastor-Pérez, F., Otero-García, Ó., Rodríguez-Santamarta, M., García-Vega, D., Fluvià, P., Donoso-Trenado, V., Sánchez-Corral, E., García-Pinilla, J. M., Bonilla-Palomas, J. L., López, A. L., González-Juanatey, J. R., & Bonet, L. A. (2025). Tachycardia-induced cardiomyopathy in de novo heart failure: prevalence, short-term outcomes, and the role of guideline-directed therapy in ejection fraction improvement. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-025-02663-y

Source records